Cargando…
MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
Acquisition of resistance to docetaxel (Doc) is one of the most important problems in treatment of breast cancer patients, but the underlying mechanisms are still not fully understood. In present study, Doc-resistant MDA-MB-231 and MCF-7 breast cancer cell lines (MDA-MB-231/Doc and MCF-7/Doc) were s...
Autores principales: | Zhang, Xiaohui, Zhong, Shanliang, Xu, Yong, Yu, Dandan, Ma, Tengfei, Chen, Lin, Zhao, Yang, Chen, Xiu, Yang, Sujin, Wu, Yueqin, Tang, Jinhai, Zhao, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821636/ https://www.ncbi.nlm.nih.gov/pubmed/27045586 http://dx.doi.org/10.1371/journal.pone.0153194 |
Ejemplares similares
-
MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes
por: Zhong, Shanliang, et al.
Publicado: (2016) -
Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway
por: Chen, Sheng, et al.
Publicado: (2017) -
GSK3β Is Involved in JNK2-Mediated β-Catenin Inhibition
por: Hu, Dong, et al.
Publicado: (2009) -
microRNA-3646 serves as a diagnostic marker and mediates the inflammatory response induced by acute coronary syndrome
por: Yu, Jinming, et al.
Publicado: (2021) -
MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway
por: Sun, Jiling, et al.
Publicado: (2015)